You have 9 free searches left this month | for more free features.

Condition

Advanced Cancer (1)

Breast Cancer (1)

Metastatic Castration-resistant Prostate Cancer (1)

Ovarian Cancer (1)

Recurrent Epithelial Ovarian Cancer (1)

Recurrent High-grade Glioma (1)

Overall Status

Recruiting (2)

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (3)

phase 1 (1)

Sponsor

Onxeo (2)

Gustave Roussy, Cancer Campus, Grand Paris (1)

Institut Curie (1)

Collaborator

Intervention

asidna (4)

olaparib (2)

niraparib (1)

rucaparib (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (4)

asidna

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastatic Castration-resistant Prostate Cancer, Recurrent Epithelial Ovarian Cancer, Breast Cancer Trial (AsiDNA, Olaparib)

Not yet recruiting

Metastatic Castration-resistant Prostate Cancer
+2 more

AsiDNA
Olaparib

(no location specified)

Jan 17, 2023

Recurrent High-grade Glioma Trial in France (AsiDNA)

Recruiting

Recurrent High-grade Glioma

AsiDNA

Angers, France
+9 more

Sep 2, 2022

Advanced Cancer Trial in Belgium, France (AsiDNA)

Completed

Advanced Cancer

AsiDNA

Bruxelles, Belgium
+4 more

Mar 23, 2022

Ovarian Cancer Trial in Villejuif (AsiDNA, Niraparib, Olaparib)

Recruiting

Ovarian Cancer

AsiDNA
+3 more

Villejuif, Val De Marne, France

Gustave Roussy

Sep 27, 2021